ACUTA CAPITAL PARTNERS LLC

ACUTA CAPITAL PARTNERS LLC latest Q4_2020 13F filings reported $363,194,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 6.71%. This fund has 50 securities concentrations of 100% weights.

ACUTA CAPITAL PARTNERS LLC largest holding is Celldex Therapeutics Inc. with weight of 7.85% and $28,514,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR50$363,194,0006.71%
2020-11-162020-09-30Q3_202013F-HR42$340,366,000-1.66%
2020-08-142020-06-30Q2_202013F-HR46$346,112,00067.76%
2020-05-152020-03-31Q1_202013F-HR32$206,318,000-41.33%
2020-02-142019-12-31Q4_201913F-HR35$351,657,000176.66%
2019-11-142019-09-30Q3_201913F-HR30$127,106,000-50.98%
2019-08-142019-06-30Q2_201913F-HR27$259,307,00024.91%
2019-05-142019-03-31Q1_201913F-HR31$207,597,00078.59%
2019-02-142018-12-31Q4_201813F-HR18$116,243,000-53.42%
2018-11-072018-09-30Q3_201813F-HR23$249,568,000-50.76%
2018-08-152018-06-30Q2_201813F-HR37$506,858,0006.20%
2018-05-152018-03-31Q1_201813F-HR30$477,267,00018.44%
2018-02-142017-12-31Q4_201713F-HR31$402,968,0008.66%
2017-11-142017-09-30Q3_201713F-HR35$370,868,00051.40%
2017-08-142017-06-30Q2_201713F-HR35$244,962,000-11.41%
2017-05-152017-03-31Q1_201713F-HR41$276,509,00010.24%
2017-02-132016-12-31Q4_201613F-HR38$250,830,0003.03%
2016-11-142016-09-30Q3_201613F-HR53$243,450,00022.58%
2016-08-152016-06-30Q2_201613F-HR56$198,606,00015.02%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
CELLDEX THERAPEUTICS INC NEWCLDXINCR$28,51424.45%7.85%$17.52-94.66%1,627,500
SAGE THERAPEUTICS INCSAGEINCR$22,12960.91%6.09%$86.51-86.31%255,800
KURA ONCOLOGY INCKURADECR$20,821-30.16%5.73%$32.66-134.48%637,500
LARIMAR THERAPEUTICS INCLRMRINCR$18,47946.76%5.09%$21.41-96.01%863,100
MERSANA THERAPEUTICS INCMRSNINCR$18,46748.58%5.08%$26.61-96.03%694,000
COMPASS PATHWAYS PLCCMPSINCR$15,19711.65%4.18%$47.64-118.21%319,000
VISTAGEN THERAPEUTICS INCVTGNBUY$14,5500.00%4.01%$1.940.00%7,500,000
ATHIRA PHARMA INCATHAINCR$13,460101.14%3.71%$34.25-91.59%393,000
IMMUNOVANT INCIMVTINCR$13,09548.84%3.61%$46.19-86.60%283,500
TRILLIUM THERAPEUTICS INCTRILDECR$11,812-2.55%3.25%$14.71-105.86%803,000
ARROWHEAD PHARMACEUTICALS INARWRINCR$10,665143.99%2.94%$76.73-63.05%139,000
89BIO INCETNBDECR$10,586-1.19%2.91%$24.37-95.95%434,400
SYNDAX PHARMACEUTICALS INCSNDXINCR$10,353191.39%2.85%$22.24-6.64%465,500
APELLIS PHARMACEUTICALS INCAPLSINCR$9,55589.58%2.63%$57.20-100.00%167,054
BCLS ACQUISITION CORPBLSABUY$9,3850.00%2.58%$11.140.00%842,500
SURFACE ONCOLOGY INCSURFINCR$9,23523.02%2.54%$9.24-108.13%999,500
CATALYST BIOSCIENCES INCCBIOINCR$8,56632.99%2.36%$6.31-109.37%1,357,500
IVERIC BIO INCISEEINCR$8,37885.11%2.31%$6.91-48.91%1,212,500
FULCRUM THERAPEUTICS INCFULCINCR$7,992164.20%2.20%$11.71-21.10%682,500
REPLIMUNE GROUP INC USD0.001000REPLBUY$7,9160.00%2.18%$38.150.00%207,500
IOVANCE BIOTHERAPEUTICS INCIOVADECR$7,647-26.26%2.11%$46.40-147.68%164,800
CONCERT PHARMACEUTICALS INCCNCEINCR$6,794130.62%1.87%$12.64-20.83%537,500
ALTIMMUNE INCALTDECR$6,525-28.15%1.80%$11.28-115.92%578,500
AVIDITY BIOSCIENCES INCRNADECR$6,283-5.02%1.73%$25.52-95.23%246,200
JIYA ACQUISITION CORPJYACBUY$5,7940.00%1.60%$10.300.00%562,500
STOKE THERAPEUTICS INCSTOKBUY$5,7290.00%1.58%$61.940.00%92,500
VERASTEM INCVSTMINCR$5,11276.03%1.41%$2.13-100.00%2,400,000
HEALTH SCIENCES ACQ CORP 2HSAQINCR$5,02816.44%1.38%$12.81-100.00%392,500
AVADEL PHARMACEUTICALS PLCAVDLINCR$4,71132.55%1.30%$6.68-100.00%705,218
CURIS INCCRISBUY$4,3410.00%1.20%$8.190.00%530,000
PRAXIS PRECISION MEDICINES IPRAXBUY$4,1620.00%1.15%$55.020.00%75,645
RAPT THERAPEUTICS INCRAPTDECR$4,140-46.43%1.14%$19.75-112.67%209,600
RELMADA THERAPEUTICS INCRLMDDECR$3,848-63.07%1.06%$32.07-156.68%120,000
C4 THERAPEUTICS INCCCCCBUY$3,6440.00%1.00%$33.130.00%110,000
MADRIGAL PHARMACEUTICALS INCMDGLBUY$3,6130.00%0.99%$111.170.00%32,500
CLEARSIDE BIOMEDICAL INCCLSDINCR$3,425261.67%0.94%$2.743.25%1,250,000
CYMABAY THERAPEUTICS INCCBAYDECR$1,894-65.81%0.52%$5.74-156.86%330,000
ONCORUS INCONCRBUY$1,7300.00%0.48%$32.340.00%53,500
ALDEYRA THERAPEUTICS INCALDXDECR$1,321-89.17%0.36%$6.86-188.31%192,500
XENON PHARMACEUTICALS INCXENEDECR$1,230-62.96%0.34%$15.38-173.33%80,000
CYCLACEL PHARMACEUTICALS INCCYCCBUY$1,1720.00%0.32%$7.810.00%150,000
ROCKET PHARMACEUTICALS INCRCKTBUY$1,0970.00%0.30%$54.850.00%20,000
PMV PHARMACEUTICALS INCPMVPBUY$9230.00%0.25%$61.530.00%15,000
4D MOLECULAR THERAPEUTICS INFDMTBUY$8290.00%0.23%$41.450.00%20,000
WAVE LIFE SCIENCES LTDWVEDECR$846-7.34%0.23%$7.870.00%107,500
ANNEXON INCANNXDECR$626-81.17%0.17%$25.04-177.27%25,000
KARUNA THERAPEUTICS INCKRTXDECR$508-51.34%0.14%$101.60-162.96%5,000
AXSOME THERAPEUTICS INCAXSMDECR$489-69.49%0.13%$81.50-173.33%6,000
NOVAVAX INCNVAXBUY$2790.00%0.08%$111.600.00%2,500
Panacea AcquisitionBUY$2990.00%0.08%$3.200.00%93,332
BIOCRYST PHARMACEUTICALS INCBCRXSOLD$00.00%-100.00%$0.000.00%0
CARDIFF ONCOLOGY INC COMCRDFSOLD$00.00%-100.00%$0.000.00%0
CYTOKINETICS CYTKSOLD$00.00%-100.00%$0.000.00%0
IMMUNOMEDICS INCIMMUSOLD$00.00%-100.00%$0.000.00%0
LIFESCI ACQUISITION CORPVINCSOLD$00.00%-100.00%$0.000.00%0
PANACEA ACQUISITION CORPSOLD$00.00%-100.00%$0.000.00%0
SELECTA BIOSCIENCES INCSELBSOLD$00.00%-100.00%$0.000.00%0
SPDR SER TRXBISOLD$00.00%-100.00%$0.000.00%0
UNUM THERAPEUTICS INCUNUMSOLD$00.00%-100.00%$0.000.00%0